Immune Checkpoint Inhibitor In High Risk Oral Premalignant Lesions
Clinical trial NCT04504552 · UNKNOWN
Trial details
- NCT number
- NCT04504552
- Sponsor
- Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-16
- Primary completion
- 2023-10-31
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.